DAVID A. GARRISON - 30 Jan 2024 Form 4 Insider Report for HARTE HANKS INC (HHS)

Role: Chief Financial Officer
Signature: /s/ Robert Wyman, Attorney-in-fact for David A Garrison
Issuer symbol: HHS
Transactions as of: 30 Jan 2024
Net transactions value: +$500,004
Form type: 4
Filing time: 01 Feb 2024, 15:41:32 UTC
Previous filing: 17 Nov 2023
Next filing: 13 May 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HHS	Option to buy Common Shares	Award	$500,004	+64,600		$7.74	64,600	30 Jan 2024	Common Stock	64,600	$7.74	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	1/3 of options vests annually on January 29, beginning in 2025 and ending in 2027.